DEC 18, 2015 08:00 AM PST

A proposed phenotyping method for Human Innate Lymphoid Cells (ILCs) using flow cytometry

Speakers
  • Flow Cytometry Marketing Manager and Application Scientist, Beckman Coulter Emerging Market Europe Asia India
    Biography
      Dr Olivier Jaen works at Beckman Coulter Emerging Market Europe Asia India as a Flow Cytometry Marketing Manager but also as application scientist. He belongs to both teams to give support and scientific expertise to customers but also internally. He is specialized in immunology and hematology of human and the mouse model system. Before joining Beckman Coulter, he completed a PhD in Paris VII University. He worked at Inserm Unit in Paris XIII Bobigny University and Avicenne Hospital for flow cytometry. Previously he worked on mouse dendritic cells and regulatory T cells in mouse autoimmunity. Another part of his PhD, was done on human rheumatoid arthritis patients. He used molecular biology to understand the role of toll like receptors single nucleotide polymorphisms in disease progression. He is now involved in the development of multicolor panels for flow cytometry research, clinical research and routine analysis.

    Abstract:
    Innate Lymphoid Cells (ILC) are lymphocytes that share the same morphological features of classical lymphocytes. They lack specific antigen receptors (Spits and Cupedo Annu Rev Immunol 2012). The ILC family contains Natural Killer cells (NK), lymphoid tissue inducer (LTi) and other ILCs (Spits et al. Nat Rev Immunol 2013). A classification was proposed in which they divided the ILC family into three different groups based on their capacity to secrete cytokines (Spits et al. Nat Rev Immunol 2013). ILC group 1 is able to secrete IFN-g, ILC group 2 is able to secrete type 2 cytokines (IL5 and IL13) and ILC group 3 is able to secrete IL17 and/or IL22. ILC could also be classified by their expression of different membrane receptors. According to Mette and collaborators, the ILC are lineage negative, CD127+, and CD161+. The classification is made on CD117, CRTh2 and NKp44. ILC1 are CD117- CRTh2- and NKp44-. ILC2 are CD117+/- and CRTh2+. ILC3 are CD117+ and NKp44+/- (Mette et al Blood 2014).  In this presentation, we will propose a method to phenotype whole blood ILCs and PBMC ILCs. We will present how to use the new CytoFLEX flow cytometer to look into these different human classical ILC. We will also see how to calculate automatic compensations, and how to set carefully the different gates using fluorescence minus one tubes.

    Learning Objectives:
    • See a proposed method to phenotype whole blood ILCs and PBMC ILCs
    • Learn how to use the new CytoFLEX flow cytometer to look into these different human classical ILC
    • Learn how to calculate automatic compensations, and how to set carefully the different gates using fluorescence minus one tubes using the CytoFLEX flow cytometer 

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    FEB 27, 2019 08:00 AM PST
    C.E. CREDITS
    FEB 27, 2019 08:00 AM PST
    DATE:  February 27, 2019TIME:  8:00am PST Pluripotent stem cells (PSCs) can form any tissue or cell in the body, and are the ideal starting material to manufacture...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    MAY 21, 2019 07:00 AM PDT
    C.E. CREDITS
    MAY 21, 2019 07:00 AM PDT
    DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
    Loading Comments...
    Show Resources